Multiple Myeloma Research Consortium
The mission of the Multiple Myeloma Research Consortium is to champion collaboration with and integration across academia and industry and to focus on speed and innovation to bring the most promising multiple myeloma treatments to patients faster. It was founded by Kathy Giusti, a myeloma patient and founder and chief executive officer of the Multiple [Myeloma Research Foundation].
MMRC model
The MMRC comprises 14 member institutions nationwide that form its clinical trials network. It is led by an executive committee in Norwalk, Connecticut, and a steering committee and progress review committee composed of researchers from MMRC Member Institutions. The MMRC also includes a shared tissue bank of annotated tissue and peripheral blood samples from multiple myeloma patients.MMRC member institutions
The MMRC currently comprises fourteen world-renowned academic institutions:- Dana–Farber Cancer Institute
- H. Lee Moffitt Cancer Center & Research Institute
- Mayo Clinic
- City of Hope National Medical Center
- Emory University, Indiana University
- Hackensack University Medical Center
- Ohio State University Comprehensive Cancer Center
- Saint Vincent Catholic Medical Center
- University Health Network
- University of California, San Francisco Medical Center
- University of Chicago
- University of Michigan Rogel Cancer Center
- Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital
- Washington University School of Medicine.